Recent News
Introducing Ventripoint: Secrets of the Unknown Ventricle
Introducing Ventripoint: Secrets of the Unknown Ventricle By Tony Pullen, Editor-at-Large [Editor’s foreword: Ventripoint CEO George Adams will be guest for a BioPub webcast at …
All Hail Hector the BioBull: The New BioPub Logo
We couldn’t hold back any longer and decided not to wait until the launch of BioPub V3.0 for the great unveiling of the new BioPub …
Is Summit’s Ridinilazole a Threat to Acurx’s Ibezapolstat in the C.difficile Space?
David Luci, CPA, JD Acurx Cofounder and Managing Partner Is Summit’s Ridinilazole a Threat to Acurx’s Ibezapolstat in the C.difficile Space? Another reason to say “I Love …
BioPub TV: Webcast Schedule for August 2020
Many switchbacks on the road ahead that remains for August……here’s an update on what to plan for. Friday, 14 August, Noon EST: Leading-edge fullerene chemistry …
Ten Good Reasons to Invest Now Pre-Market in Acurx Pharmaceuticals
As possibly the filthiest river on Earth, the Ganges has three bacteriophages for every bacterium. Which is probably why you don’t die from drinking or …
The Road Ahead: This Week at BioPub
Stay with us this week at BioPub as we prepare, Friday, to introduce you to a novel investing idea that represents a foray outside biotech. August …
Really Too. Open Table, August 2020
The scary outcome that’s become increasingly a reality for certain Covid-19 patients. In NYT this morning. Bring on the ifenprodil! (Disclosure: Long Algernon) By Denise …
New from Tony Pullen on Altum/BetterLife
CEO Ahmed Douroudian, PhD Covid Canada Revisited by Tony Pullen Dear readers, many of you will recall that I became involved with a company called …
Readers Write: Can NervGen Restore My Brother-in-Law’s Heath? A Narrative of Plight and Hope by Rebecca Adams
Jon, the author’s brother-in-law. Lonely are the brave. Readers Write: Can NervGen Restore My Brother-in-Law Jon’s Health? A Narrative of Plight and Hope by Rebecca …
Bucky Bucks? Highbrow Nanocarbon Chemistry May Be a High-Dollar Investing Opportunity for BioPub Readers
“When I am working on a problem, I never think about beauty but when I have finished, if the solution is not beautiful, I know …
NervGen Announces Capital Raise
William Radvak, Executive Chairman NervGen Pharma ($NGENF) BioPub’s Best Board Chairman in Biotech, 2020 NervGen announced today plans for a capital raise commencing immediately. Readers who …
Special Report: Should $KNWN Investors Swim For Shore?
Ron Erickson, JD….wearing no life jacket Chairman and Co-Founder Know Laboratories ($KNWN) The Pub has been dyspeptic since, late last week, longtime New Jersey reader …
Join The BioPub
Community
Register now and gain access to our medical and science forums.
Join The BioPub
Community
Register now and gain access to our medical and science forums.
BIOPUB Webcasts
BioPub is the only biotech investing forum regularly providing readers top-tier unfettered live access to biotech executives…in the form of live webcasts once or twice weekly with new companies that have evoked editorial attention and established companies in the BioPub stable of investments. Our copyrighted, exclusive webcasts are recorded and archived on this website and sometimes on our youtube channel. Have a question for which the answer will influence your investment decision? Show up and ask.
Editor-in-Chief KSS, MD, PhD, holds a monthly members-only “townhall” online gathering presenting candid views on the state of investments covered at BioPub, and new investing ideas. He’s happy to take your questions live.
BIOPUB Webcasts
BioPub is the only biotech investing forum regularly providing readers top-tier unfettered live access to biotech executives…in the form of live webcasts once or twice weekly with new companies that have evoked editorial attention and established companies in the BioPub stable of investments. Our copyrighted, exclusive webcasts are recorded and archived on this website and sometimes on our youtube channel. Have a question for which the answer will influence your investment decision? Show up and ask.
Editor-in-Chief KSS, MD, PhD, holds a monthly members-only “townhall” online gathering presenting candid views on the state of investments covered at BioPub, and new investing ideas. He’s happy to take your questions live.
Editor-in-Chief KSS, MD, PhD, holds a monthly members-only “townhall” online gathering presenting candid views on the state of investments covered at BioPub, and new investing ideas. He’s happy to take your questions live.
BioPub
a publication of Helixir Media, LLC
- KSS, MD, PhD, (New York): Founder
- Alan Harris (London): Founder
- KSS, MD, PhD, FACP: Editor-in-Chief and Publisher
- Jonathan Coulborn, MBA: Editor
- YVR Trader: Managing Editor
- Tony Pullen: Editor-at-Large
- Glenn Newberry: Editor-at-Large
- Cleveland: Contributing Editor
- cw99, MD: Associate Editor
- Paul Harte: Associate Editor
- OneMdcn: Associate Editor
EDITORIAL BOARD
- Jonathan Coulborn: MBA, Chairman
-
- Tom Nall: Tampa, Florida
- cw99, MD: Austin, TX
- KSS, MD, PhD: ex officio
- Paul Harte: San Francisco, CA
- YVR Trader: Vancouver, BC
- Melanie, MS: New York, NY
-
Original BioPub Photographic Artwork
by Michael Wideman (Tulsa, OK)
and KSS, Copyright 2017 -
"Hector the BioBull" Design by
Bryce Choquer (Vancouver, BC)
and KSS, Copyright 2020
“The individual has always had to struggle to keep from being overwhelmed by the tribe. To be your own man is a hard business. If you try it, you’ll be lonely often, and sometimes frightened. But no price is too high to pay for the privilege of owning yourself.”
“Do the things you really want to do if you possibly can. Don’t wait for circumstances to be exactly right. You’ll find that they never are.”
- Rudyard Kipling (often misattributed to Friedrich Nietzsche)
BioPub
a publication of Helixir Media, LLC
- KSS, MD, PhD, (New York): Founder
- Alan Harris (London): Founder
- KSS, MD, PhD, FACP: Editor-in-Chief and Publisher
- Jonathan Coulborn, MBA: Editor
- YVR Trader: Managing Editor
- Tony Pullen: Editor-at-Large
- Glenn Newberry: Editor-at-Large
- Cleveland: Contributing Editor
- cw99, MD: Associate Editor
- Paul Harte: Associate Editor
- OneMdcn: Associate Editor
EDITORIAL BOARD
- Jonathan Coulborn: MBA, Chairman
-
- Tom Nall: Tampa, Florida
- cw99, MD: Austin, TX
- KSS, MD, PhD: ex officio
- Paul Harte: San Francisco, CA
- YVR Trader: Vancouver, BC
- Melanie, MS: New York, NY
-
Original BioPub Photographic Artwork
by Michael Wideman (Tulsa, OK)
and KSS, Copyright 2017 -
"Hector the BioBull" Design by
Bryce Choquer (Vancouver, BC)
and KSS, Copyright 2020
Company Contact
- leon@biopub.co
- 4711 Hope Valley Road, Suite 4F, Durham, NC 27707
